title: Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.
authors.affiliation: Infectious Diseases Society of America Antimicrobial Availability Task Force, USA. bspellberg@labiomed.org
authors.forename: Brad
authors.initials: B
authors.lastname: Spellberg
authors.forename: George H
authors.initials: GH
authors.lastname: Talbot
authors.forename: Eric P
authors.initials: EP
authors.lastname: Brass
authors.forename: John S
authors.initials: JS
authors.lastname: Bradley
authors.forename: Helen W
authors.initials: HW
authors.lastname: Boucher
authors.forename: David N
authors.initials: DN
authors.lastname: Gilbert
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy*; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents